about
Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatmentRegulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cellsImaging biochemistry: applications to breast cancerAdvances in computed tomography and magnetic resonance imaging of hepatocellular carcinomaThe human plasma lipidomeCholine metabolism-based molecular diagnosis of cancer: an updateMagnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cellsHDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cellsIdentification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance SpectrometryCholine-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasisEnhancement of chemotherapy by manipulation of tumour pH.Adiabatic multi-echo ³¹P spectroscopic imaging (AMESING) at 7 T for the measurement of transverse relaxation times and regaining of sensitivity in tissues with short T₂ values.1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components.Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin.Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.Advanced magnetic resonance imaging of the physical processes in human glioblastoma.The development of functional imaging in the diagnosis, management and understanding of childhood brain tumours.Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy.Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.Recent advances in magnetic resonance neurospectroscopy.Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status.Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantation.High spatial resolution and speed in MRSI.The potential of proton beam radiation therapy in intracranial and ocular tumours.SpectraClassifier 1.0: a user friendly, automated MRS-based classifier-development systemInhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft modelsActivation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.The INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses.In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer1H/31P polarization transfer at 9.4 Tesla for improved specificity of detecting phosphomonoesters and phosphodiesters in breast tumor models.The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.Contribution of kinetic characteristics of axillary lymph nodes to the diagnosis in breast magnetic resonance imaging.Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene ExpressionAn HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsyModulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition.
P2860
Q24317541-1E0CB6FE-2AA4-4B44-AEB1-6FCF28AC1276Q24646815-460B5CEA-8493-4DED-926B-7EB35F610E09Q24801126-AEF428F3-B70C-4922-879B-FC2CF326BDECQ26772334-B13BEB3D-8079-4061-9578-F5872F5F40D3Q26830940-623DFFF7-455F-4BDD-9B74-AECD2B4EDA51Q27024079-118F0794-BCFE-4AC8-9557-B8107E4A17AAQ28359571-90591752-B18D-45EF-816D-877292CC32F6Q28486529-D5FC9EB0-116E-4714-81F5-F7A7FA410C5EQ28553966-AAEC5407-AAA8-454B-A2C7-468B10619C08Q30514230-D64BE8D4-A905-4C36-A294-24E086FC64FFQ30578111-64F8A753-59CD-4EDF-B9DC-F9844B23A2DEQ30611800-961B82C6-8A0C-4C85-AF68-8AD6D3EA2A55Q30657505-F6292534-F631-40B6-BC63-45999B5FA5C6Q30744878-00E3C340-623B-4B8C-AB97-C529FE004D86Q30808489-9162CE9F-0059-434A-9C68-14E7A89F0256Q30847284-F717AB2D-3F24-4A79-B951-BB6A54F9F3EAQ30971165-15D5F0E4-95B8-4A3A-B8C6-00963526E75BQ30977535-A171BC5C-FCDD-4A9A-8625-AE8EC5703343Q31009512-FA81651D-1AC7-4559-B37E-C8B83DE635ADQ31044575-6FBE9A6D-6C4D-4B2B-BC96-5A18E938AAE5Q31117145-EED5BBA1-A998-4D66-A3F3-93399357DC15Q32053101-561F8AB1-6F66-4CEB-AE19-596EBE8AE182Q32067140-75501845-80E0-4065-BA7D-54556E1221DBQ32067987-BEDD3700-73E9-484A-9B9A-7E3D4E4C1613Q33272454-E7BAD706-0B10-4335-A191-12C9E9EE1832Q33534056-E0301C03-1A90-44A4-A279-FD6C139EAE92Q33576337-E71D3271-624D-4DA5-A826-C17744A62B8FQ33660965-6203C1B2-2552-455A-B254-140860B3F2C5Q33699139-17370CD9-BCAD-4C17-9E30-86B86D85D64FQ33757835-30429B0C-4507-42A9-8F78-DBCE16B63E8CQ33817177-5367B402-2F52-422B-969A-B4EF5102399BQ33844954-E38F7D33-FACC-42BD-8C5B-5A90D55DB6C5Q33881902-37506557-9DD8-4E15-B7D3-50F8EC6876B6Q33921319-1A992CBD-337B-4B1E-89B1-2AC691566DA8Q33959529-69202DC4-23F7-4F7C-B014-15E77993A75EQ33973510-C3C20EB2-41A7-4270-939C-65AABC93B6B0Q34035237-09C3CADF-D05C-49FA-B0B5-1C185B205767Q34041364-78F262AC-5463-42F4-A7A7-7CB77D1012E3Q34058288-080071F4-C9EE-4E17-A4F4-88C3ED9998E2Q34249948-92D9FFB9-2C19-43CC-8FC6-30967F05A13D
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Studies of human tumors by MRS: a review.
@ast
Studies of human tumors by MRS: a review.
@en
type
label
Studies of human tumors by MRS: a review.
@ast
Studies of human tumors by MRS: a review.
@en
prefLabel
Studies of human tumors by MRS: a review.
@ast
Studies of human tumors by MRS: a review.
@en
P2860
P356
P1433
P1476
Studies of human tumors by MRS: a review.
@en
P2093
Negendank W
P2860
P304
P356
10.1002/NBM.1940050518
P577
1992-09-01T00:00:00Z